Clinical Responses and Synovial Vascularity in Obese Rheumatoid Arthritis Patients Treated with Adalimumab and Methotrexate

被引：0

作者：

Kaeley, Gurjit S. ^{[1
]}

Ranganath, Veena K. ^{[2
]}

MacCarter, Daryl K. ^{[3
]}

Pangan, Aileen L. ^{[4
]}

Wang, Xin ^{[4
]}

Kalabic, Jasmina ^{[5
]}

机构：

[1] Univ Florida, Jacksonville, FL USA

[2] Univ Calif Los Angeles, Los Angeles, CA USA

[3] North Valley Hosp, Whitefish, MT USA

[4] AbbVie Inc, N Chicago, IL USA

[5] AbbVie Deutschland GmbH & Co KG, Ludwigshafen, Germany

来源：

ARTHRITIS & RHEUMATOLOGY | 2016年 / 68卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

640

引用

页数：4

共 50 条

[41] The addition of adalimumab to methotrexate reduces rheumatoid arthritis activity in patients with longstanding disease
Matucci-Cerinic, M
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2004, 22 (01) : 34 - 35
[42] Predictors of Clinical Response and Radiographic Progression in Patients with Rheumatoid Arthritis Treated with Methotrexate Monotherapy
Drouin, Julie
Haraoui, Boulos
JOURNAL OF RHEUMATOLOGY, 2010, 37 (07) : 1405 - 1410
[43] FOLIC ACID SUPPLEMENTATION DELAYS CLINICAL IMPROVEMENT IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH METHOTREXATE
Sulli, A.
Pizzorni, C.
Paolino, S.
Tomatis, V.
Ghio, M.
Ruaro, B.
Cutolo, M.
ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1401 - 1401
[44] Leflunomide improves the clinical response in patients with active rheumatoid arthritis treated with methotrexate - Comment
Van Riel, P
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2003, 21 (06) : 696 - 696
[45] Significant clinical improvements at 6 months are sustained over 4 years in patients with rheumatoid arthritis treated with adalimumab (HUMIRA®) plus methotrexate.
Schiff, MH
Weisman, MH
Cohen, SB
Kavanaugh, AF
Spencer-Green, GT
Perez, JL
Mydler, TT
Segurado, OG
ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S182 - S183
[46] Time lag between the initiation of adalimumab after methotrexate correlates with the efficacy of adalimumab in rheumatoid arthritis patients
Kimura, Noriko
Suzuki, Katsuya
Takeuchi, Tsutomu
MODERN RHEUMATOLOGY, 2016, 26 (05) : 676 - 680
[47] Serious infection rates remain stable in patients with rheumatoid arthritis treated with adalimumab in clinical trials
Kent, J
Pangan, A
Sasso, E
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : AB207 - AB207
[48] Disease Flares Among Early Rheumatoid Arthritis Patients Treated with Continued Methotrexate Either Alone or in Combination with Adalimumab (Humira)
Kavanaugh, Arthur
van Vollenhoven, Ronald F.
Sunkureddi, Prashanth
Zhang, Ying
Suboticki, Jessica L.
Smolen, Josef S.
ARTHRITIS & RHEUMATOLOGY, 2017, 69
[49] Inhibition of radiographic progression in patients with long-standing rheumatoid arthritis treated with adalimumab plus methotrexate for 5 years
Keystone, E. C.
Kavanaugh, A. F.
Sharp, J. T.
Patra, K.
Perez, J. L.
ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 176 - 176
[50] DISEASE FLARES AMONG EARLY RHEUMATOID ARTHRITIS PATIENTS TREATED WITH CONTINUED METHOTREXATE EITHER ALONE OR IN COMBINATION WITH ADALIMUMAB (HUMIRA)
Kavanaugh, A.
van Vollenhoven, R. F.
Sunkureddi, P.
Zhang, Y.
Suboticki, J. L.
Smolen, J. S.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 : S75 - S76

← 1 2 3 4 5 →